Latif AD, Jernei T, Podolski-Renić A, Kuo CY, Vágvölgyi M, Girst G, Zupkó I, Develi S, Ulukaya E, Wang HC, Pešić M, Csámpai A, Hunyadi A. Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling. Antioxidants (Basel). 2020 Jun 12;9(6):E519. doi: 10.3390/antiox9060519.

Gieszinger P, Stefania Csaba N, Garcia-Fuentes M, Prasanna M, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Janáky T, Kecskeméti G, Katona G, Szabó-Révész P, Ambrus R. Preparation and characterization of lamotrigine containing nanocapsules for nasal administration. Eur J Pharm Biopharm. 2020 Jun 9:S0939-6411(20)30168-5. doi: 10.1016/j.ejpb.2020.06.003.

Behzadi P, Urbán E, Gajdács M. Association between Biofilm-Production and Antibiotic Resistance in Uropathogenic Escherichia coli (UPEC): An In Vitro Study. Diseases. 2020 Jun 7;8(2):E17. doi: 10.3390/diseases8020017.

Gajdács M. Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing. Antibiotics (Basel). 2020 Apr 1;9(4):153. doi: 10.3390/antibiotics9040153.

Csupor D, Kurtán T, Vollár M, Kúsz N, Kövér KE, Mándi A, Szűcs P, Marschall M, Senobar Tahaei SA, Zupkó I, Hohmann J. Correction to Pigments of the Moss Paraleucobryum longifolium: Isolation and Structure Elucidation of Prenyl-Substituted 8,8'-Linked 9,10-Phenanthrenequinone Dimers. J Nat Prod. 2020 Apr 24;83(4):1355. doi: 10.1021/acs.jnatprod.0c00243.

Gajdács M, Ábrók M, Lázár A, Terhes G, Urbán E. Anaerobic blood culture positivity at a University Hospital in Hungary: A 5-year comparative retrospective study. Anaerobe. 2020 Apr 1;63:102200. doi: 10.1016/j.anaerobe.2020.102200.

Alshweiat A, Csóka I, Tömösi F, Janáky T, Kovács A, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Szabó-Révész P, Ambrus R. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation. Int J Pharm. 2020 Apr 15;579:119166. doi: 10.1016/j.ijpharm.2020.119166.

Gajdács M, Urbán E. Relevance of anaerobic bacteremia in adult patients: A never-ending story? Eur J Microbiol Immun. 2020. Online. doi: 10.1556/1886.2020.00009.

Gajdács M, Szabó A. Orovosok antibiotikum felhasználással és –rezisztenciával kapcsolatos véleményének vizsgálata Magyarország délkeleti részén. Orvosi Hetilap. 2020; 161(9): 330-339. doi: 10.1556/650.2019.31598.

Ambrus R, Gieszinger P, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Janáky T, Tömösi F, Kecskeméti G, Szabó-Révész P, Bartos C.Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity. Molecules. 2020 Feb 27;25(5):1065. doi: 10.3390/molecules25051065.

Aslam A, Gajdács M, Zin CS, Binti Abd Rahman NS, Ahmed SI, Jamshed SQ. Public Awareness and Practices towards Self-Medication with Antibiotics among the Malaysian Population. A Development of Questionnaire and Pilot-Testing. Antibiotics (Basel). 2020 Feb 24;9(2):97. doi: 10.3390/antibiotics9020097.

Keglevich A, Dányi L, Rieder A, Horváth D, Szigetvári Á, Dékány M, Szántay Cs, Latif AD, Hunyadi A, Zupkko I, Keglevich P, Hazai L. Synthesis and Cytotoxic Activity of New Vindoline Derivatives Coupled to Natural and Synthetic Pharmacophores. Molecules. 2020. February 25(4). doi: 10.3390/molecules25041010

Katona G, Balogh GT, Dargó G, Gáspár R, Márki Á, Ducza E, Sztojkov-Ivanov A, Tömösi F, Kecskeméti G, Janáky T, Kiss T, Ambrus R, Pallagi E, Szabó-Révész P, Csóka I.Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach. Pharmaceutics. 2020 Jan 25;12(2). pii: E97. doi: 10.3390/pharmaceutics12020097.

Gajdács M, Paulik E, Szabó A. Knowledge, Attitude and Practice of Community Pharmacists Regarding Antibiotic Use and Infectious Diseases: A Cross-Sectional Survey in Hungary (KAPPhA-HU). Antibiotics (Basel). 2020 Jan 21;9(2). pii: E41. doi: 10.3390/antibiotics9020041.

Gajdács M, Bátori Z, Ábrók M, Lázár A, Burián K. Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis. Life (Basel). 2020 Feb 11;10(2). pii: E16. doi: 10.3390/life10020016.

Gajdács M. Isolation and Antibiotic Resistance of Achromobacter xylosoxidans from Non-respiratory Tract Clinical Samples: A 10-year Retrospective Study in a Tertiary-care Hospital in Hungary. Journal of Pharmaceutical Research International. 2020 32(1): 1-7. doi: https://doi.org/10.9734/jpri/2020/v32i130387

Urbán E, Terhes G, Gajdács M. Extraintestinal Clostridioides difficile Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature. Antibiotics (Basel). 2020 Jan 2;9(1). pii: E16. doi: 10.3390/antibiotics9010016.